✦ LIBER ✦

1WS02-6 Treatment with statin and beta-blockers in high risk patients with acute myocardial infarction

✍ Scribed by Kjekshus, J.; Hognestad, A.

Book ID: 118631448
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 57 KB
Volume: 4
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(03)90057-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Usefulness of Beta Blockers in High-Risk

Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial)

✍ Robert M. Califf; Yuliya Lokhnygina; Eric J. Velazquez; John J.V. McMurray; Jeff 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 617 KB

Beta Blocker Therapy After Acute Myocard

Beta Blocker Therapy After Acute Myocardial Infarction in Patients with Heart Failure and Systolic Dysfunction

✍ Emil Thattassery; Mihai Gheorghiade 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 149 KB

Effect of combined statin and beta-block

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure

✍ Aina Hognestad; Kenneth Dickstein; Eivind Myhre; Steven Snapinn; John Kjekshus 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Beta blockers and the primary prevention

Beta blockers and the primary prevention of nonfatal myocardial infarction in patients with high blood pressure

✍ Bruce M. Psaty; Thomas D. Koepsell; Edward H. Wagner; James P. LoGerfo; Thomas S 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 406 KB

Decreased mortality associated with stat

Decreased mortality associated with statin treatment in patients with acute myocardial infarction and lymphotoxin-alpha C804A polymorphism

✍ Suna, Shinichiro; Sakata, Yasuhiko; Nakatani, Daisaku; Okuda, Keiji; Shimizu, Ma 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 540 KB

Successful identification and management

Successful identification and management of high-risk patients with acute myocardial infarction

✍ R. David Anderson; E. Magnus Ohman 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 860 KB

The decision to use thrombolytic therapy in patients with acute myocardial infarction has been validated in recent large clinical trials. The identification of the high-risk patient, whether or not to use adjunctive strategies, and which patients may benefit from them are less clear. This article pr